Study highlights 'systematic opposition' to regulation in tackling NCDs from food industry

September 11, 2020

A new study out this week during the Global Week for Action on non-communicable diseases (NCDs) highlights that global public health regulation intended to tackle unhealthy diets, a key risk factor for NCDs, is being consistently opposed by the food and drinks lobby.

NCDs, such as heart disease, cancer, and diabetes, account for over 70% for global death and disability but failure to implement co-ordinated and targeted action has led to a growing problem - evidenced through the current obesity crisis facing much of the world.

The new research, from health policy analysts at Bath in collaboration with researchers from the universities of Edinburgh and São Paulo, and the World Public Health Nutrition Association, examined all food industry responses to consultations held by the World Health Organization (WHO) on NCD policy and governance between September 2015 and September 2018.

By evaluating responses across five separate consultations run by the WHO throughout this period, the work shows that, despite a rhetoric of support for public health, food industry groups consistently oppose effective regulations such as taxes and marketing restrictions, and advocate for weaker voluntary and partnership approaches instead.

Lobby groups also challenged established public health evidence about tackling NCDs. For example, the International Council of Beverages Associations which represents the soft drinks industry questioned the well-established link between sugar-sweetened beverages and obesity suggesting:

'The overall weight of the scientific evidence on sugar and/or sugar-sweetened beverages show that they do not have a unique effect on body weight beyond their contribution to total calorie intake.'

In addition, the lobby group inaccurately argued that the world's leading public health agency was not in a position to advise on health taxes:

'Offering such policy advice in a field - economics and fiscal policy - far from WHO's expertise is not in our opinion a prudent course of action.'

In fact, argue the researchers, the WHO includes among its staff many economists and the World Bank also promotes the use of health taxes.

The researchers suggest that the arguments used are similar to those deployed by the tobacco industry when the WHO started to take stronger action to regulate cigarettes in the early 2000s. These included claiming that regulation would not work or was not needed, and questioning the science and evidence underlying policies such as sugar-sweetened beverage taxation.

Recognising that good health is essential to development, the UN's landmark Sustainable Development Goals (SDGs) include a target to promote health and reduce premature mortality from NCDs by one third by 2030 (SDG 3). The COVID-19 pandemic, which affects people living with NCDs more severely, has shown how important this is.

Yet, the researchers highlight a possible tension between this goal, to improve health, and another, SDG 17, which promotes public-private partnerships. They document how food industry groups use the latter to promote industry involvement in policymaking, which for many is seen to be undermining attempts to improve health. A number of groups used SDG 17 to oppose a tool developed by the WHO to help member states protect nutrition programmes against conflicts of interest, arguing that such limitations on engagement with the food industry would not be coherent with the partnership aim promoted by the goal.

Lead author, Kathrin Lauber from the Tobacco Control Research Group at the University of Bath explains: "What happens at the WHO, and what doesn't happen, is important to all of us. The agency's guidelines can provide countries with a mandate to introduce crucial public health protections, which is why we see food and drink lobby groups pushing to keep the policy recommendations weak. Moreover, positioning collaboration with the commercial sector as a default risks impeding not only the work of the WHO as the UN's key health agency, but also that of countries across the world working to reduce the burden of NCDs."

Lucy Westerman, Policy and Campaigns Manager, NCD Alliance said: "As one of the many civil society advocates who engaged tirelessly in these same nutrition and noncommunicable disease (NCD) related WHO consultations and processes between 2015-2018, and who witnessed engagement of industry in some of these processes and related negotiations and outcomes, this analysis is extremely welcome and enlightening. The researchers' analysis illuminates but one of many ways in which such unhealthy commodity industries seek to dilute global health policy undermining efforts to ensure all people have access to healthy, nutritious diets. If we are to realise nutrition, NCD and Sustainable Development Goal targets and health for all, these industries cannot be allowed to dilute public health policy."

This study was funded by the Roger and Sue Whorrod PhD Studentship. Professor Anna Gilmore and Kathrin Lauber are members of SPECTRUM, a UK Prevention Research Partnership (UKPRP) Consortium.

'Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations' is published in the journal Globalization and Health

University of Bath

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to